We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Human Liver Organoids Thrive When Transplanted into Mouse Liver Failure Model

By LabMedica International staff writers
Posted on 13 Sep 2016
Print article
Image: A biodegradable scaffold (left) and human tissue-engineered liver (right) (Photo courtesy of the Saban Research Institute at Children\'s Hospital Los Angeles).
Image: A biodegradable scaffold (left) and human tissue-engineered liver (right) (Photo courtesy of the Saban Research Institute at Children\'s Hospital Los Angeles).
Liver disease researchers have demonstrated in a mouse model that it may be feasible to treat some types of liver failure with transplanted multicellular liver organoid units composed of a heterogeneous cellular population that includes adult stem and progenitor cells.

Liver disease affects large numbers of patients, yet there are limited treatments available to replace absent or ineffective cellular function of this crucial organ. The only effective therapy for end-stage liver failure is liver transplantation, which is profoundly limited by scarce donor supply and the necessity for life-long immunosuppression treatment. On the other hand, in some conditions, such as inborn errors of metabolism or transient states of liver insufficiency, patients may be treated by providing partial quantities of functional liver tissue.

In order to develop a robust means for transplanting functional donor liver tissue, investigators at The Saban Research Institute of Children's Hospital Los Angeles (CA, USA) transplanted multicellular human or mouse liver organoid units composed of a heterogeneous cellular population that included adult stem and progenitor cells into a mouse model of inducible liver failure.

They reported in the August 30, 2016, online edition of the journal Stem Cells Translational Medicine that both mouse and human tissue-engineered liver (TELi) formed in the animals. TELi contained normal liver components such as hepatocytes with albumin expression, CK19-expressing bile ducts and vascular structures with alpha-smooth muscle actin expression, desmin-expressing stellate cells, and CD31-expressing endothelial cells. After four weeks, TELi contained proliferating albumin-expressing cells, and identification of beta-2-microglobulin-expressing cells demonstrated that the majority of human TELi in the mice was composed of transplanted human cells. Human albumin was detected in the host mouse serum, indicating the development of in vivo secretory function.

"Based on the success in my lab generating tissue-engineered intestine and other cell types, we hypothesized that by modifying the protocol used to generate intestine, we would be able to develop liver organoid units that could generate functional tissue-engineered liver when transplanted," said senior author Dr. Tracy C. Grikscheit, professor of surgery at The Saban Research Institute of Children's Hospital Los Angeles.

Related Links:
The Saban Research Institute of Children's Hospital Los Angeles

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.